Article

Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital

Division of Pathology, Norwegian Radium Hospital, Rikshospitalet University Hospital, Oslo, Norway.
Acta oncologica (Stockholm, Sweden) (Impact Factor: 3.71). 05/2008; 47(8):1475-82. DOI: 10.1080/02841860802047387
Source: PubMed

ABSTRACT The aim of this study was to determine the prevalence and outcome of radiation-induced sarcomas (RISs) among sarcoma patients referred to the Norwegian Radium Hospital (NRH).
Ninety patients were identified from the institutional sarcoma data base. Medical records and histological and cytological material from both primary and secondary tumours were reviewed.
RIS represented 3.0 % of the sarcomas in the data base. The median latency time from radiotherapy of the primary tumour to the diagnosis of RIS was 13.6 years (range 2.5-57.8 years). Gynaecological, breast and testicular cancers were the most common primary diagnoses. For the RISs 13 different histological types were identified including 25 malignant fibrous histiocytomas (28% of all) and 22 osteosarcomas (24%). The sarcoma-related 5-year crude survival was 33% (95 % CI 23-43 %). Unfavourable prognostic factors were metastases at presentation, incomplete surgery and presence of tumour necrosis.
Radiation-induced sarcoma is rare and harbours an aggressive clinical behaviour. Complete surgical resection is mandatory for cure.

Download full-text

Full-text

Available from: Kirsten Sundby Hall, Jan 12, 2015
0 Followers
 · 
100 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aims to provide reasons for the poor sarcoma-related survival in patients with radiation-induced sarcoma (RIS).Methods:We performed a case-control study comparing sarcoma-related survival of 98 patients with RIS to that of 239 sporadic high-grade malignant sarcomas. The cumulative sarcoma-related 5-year survival was 32% (95% confidence interval (CI): 22-42) for patients with RIS vs 51% (95% CI: 44-58) for controls (P<0.001). Female gender, central tumour site and incomplete surgical remission were significantly more frequent among RIS patients than in controls. In multivariate analysis incomplete surgical remission (hazard ratio (HR) 4.48, 95% CI: 3.08-6.52), metastases at presentation (HR 2.93, 95% CI: 1.95-4.41), microscopic tumour necrosis (HR 1.88, 95% CI: 1.27-2.78) and central tumour site (HR 1.71, 95% CI: 1.18-2.47) remained significant adverse prognostic factors, but not sarcoma category (RIS vs sporadic). The poor prognosis of RIS patients are not due to the previous radiotherapy per se, but related to the unfavourable factors - central tumour site, incomplete surgical remission, microscopic tumour necrosis and the presence of metastases, the two former factors overrepresented in RIS.
    British Journal of Cancer 12/2011; 106(2):297-306. DOI:10.1038/bjc.2011.559 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To study the clinical and histological features of radiation-induced sarcoma in the head and neck (RISHN). Medical records of 13 patients with RISHN treated at our institution between 1990 and 2011 were studied, and paraffin-embedded samples were analyzed by haematoxylin and eosin staining and immunohistochemistry to determine mitosis counts and assess expression of Ki-67, bcl-2, and survivin. Positive bcl-2 was observed in 12 (100%) and survivin in 10 (76.9%) patients. The Ki-67 labeling index ranged from 1% to 90%, and it showed significant positive correlation with mitosis count in RISHN tissues, based on Spearman analysis. Percentage of distal metastasis with T2b was significantly higher than T1b stage (P=0.035). Stage T2b may be a useful indicator for predicting distant metastasis of RISHN. The MIB-1 score may be used as a histological grading system for RISHN. In addition, bcl-2 and survivin protein may play an important role in pathogenesis and progression of RISHN.
    Asian Pacific journal of cancer prevention: APJCP 01/2011; 12(11):2995-9. · 2.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The HARP experiment at CERN is performing extensive measurements of hadron production cross sections and secondary particle yields in the energy range 2-15 GeV over the full solid angle, using a large set of cryogenic and solid targets. Hadron production in this kinematic region is a relevant ingredient in several branches of neutrino physics, such as characterisation of neutrino beams, precise prediction of atmospheric neutrino fluxes, and measurement of pion production and capture for neutrino factory design. An overall precision of a few percent is required from the experiment to reach the final aim. First measurements of hadron production cross sections in the forward region (up to about 300 mrad), using a replica of the K2K target and a proton beam of 12.9 GeV/c, are reported. This is an appealing physics case, given the immediate interest for these experiments and for the neutrino community.
    Nuclear Physics B - Proceedings Supplements 05/2005; 142:448-452. DOI:10.1016/j.nuclphysbps.2005.01.077 · 0.88 Impact Factor